STAT+: HHS asks Justice Department to probe Hims & Hers over its cheaper compounded version of Wegovy
FDA will take “decisive steps” to thwart companies from mass marketing unapproved, compounded versions of GLP-1 drugs
⚠️ 风险分析 中
摘要：美国HHS要求司法部调查Hims & Hers销售未经批准的GLP-1药物仿制品。
影响：在美销售未经批准仿制药物的远程医疗公司面临司法调查和FDA打击风险，可能影响其业务运营。
建议：立即审查药品合规性，停止销售未批准药物，准备应对监管调查和法律程序。
「素履以往」
Not the sharpest mind, but the steadiest hand.
Not the sharpest mind, but the steadiest hand.